Loading...
XHKG0928
Market cap10mUSD
Dec 23, Last price  
0.04HKD
1D
-2.22%
1Q
-42.11%
Jan 2017
-98.72%
Name

Life Healthcare Group Ltd

Chart & Performance

D1W1MN
XHKG:0928 chart
P/E
5.15
P/S
0.35
EPS
0.01
Div Yield, %
0.00%
Shrs. gr., 5y
9.01%
Rev. gr., 5y
29.77%
Revenues
234m
+4.39%
1,528,999,0001,655,166,0001,942,545,000259,175,000107,684,00055,648,00053,694,00056,516,00033,339,00022,469,0008,398,0005,114,00026,875,00062,790,00063,487,00063,805,000102,041,00092,873,000223,853,000233,681,000
Net income
16m
P
154,719,000132,626,000314,639,000-2,595,622,000-97,162,000-59,239,000-93,138,0001,293,771,000-125,987,000-110,804,000-45,333,000-34,337,000-33,728,000-90,525,000-117,253,000-24,854,000-4,583,000-34,458,000-25,192,00015,818,000
CFO
-32m
L-75.97%
114,748,00051,904,000121,640,00036,097,000381,791,000-8,731,000-2,356,000-67,038,000-131,399,000-41,341,000-24,097,000-37,865,000-117,219,000-199,859,000-54,763,000173,588,000-181,342,00096,864,000-134,479,000-32,319,000

Profile

Life Healthcare Group Limited, an investment holding company, provides genetic testing and health data analysis services in the People's Republic of China and Hong Kong. The company operates through two segments, Healthcare Products and Services Business, and Money Lending Business. It offers a range of services and solutions for medical and health administration through its non-invasive tumor genetic testing technology. The company also engages in apparel retail; securities trading and investment; and money lending activities. In addition, it provides corporate administrative and healthcare services. The company was formerly known as Tack Fiori International Group Limited and changed its name to Life Healthcare Group Limited in June 2017. Life Healthcare Group Limited was incorporated in 2001 and is based in Wan Chai, Hong Kong.
URL
http://www.lifehealthcare.com/
IPO date
Apr 29, 2002
Employees
13
Domiciled in
HK
Incorporated in
KY

Valuation

Title
HKD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑032015‑03
Income
Revenues
233,681
4.39%
223,853
141.03%
92,873
-8.98%
Cost of revenue
216,047
256,376
124,534
Unusual Expense (Income)
NOPBT
17,634
(32,523)
(31,661)
NOPBT Margin
7.55%
Operating Taxes
8,756
1,044
631
Tax Rate
49.65%
NOPAT
8,878
(33,567)
(32,292)
Net income
15,818
-162.79%
(25,192)
-26.89%
(34,458)
651.87%
Dividends
Dividend yield
Proceeds from repurchase of equity
18,844
26,365
BB yield
Debt
Debt current
3,274
4,265
249
Long-term debt
5,640
4,924
346
Deferred revenue
Other long-term liabilities
(1)
(1)
Net debt
6,321
(10,848)
(141,879)
Cash flow
Cash from operating activities
(32,319)
(134,479)
96,864
CAPEX
(214)
(13)
Cash from investing activities
1,000
94,859
(67,827)
Cash from financing activities
17,386
27,401
(830)
FCF
51,955
(224,868)
237,182
Balance
Cash
473
17,786
37,402
Long term investments
2,120
2,251
105,072
Excess cash
8,844
137,830
Stockholders' equity
(1,210,910)
(1,241,898)
(1,197,994)
Invested Capital
1,482,666
1,476,699
1,457,556
ROIC
0.60%
ROCE
6.49%
EV
Common stock shares outstanding
1,641,256
1,475,135
1,285,025
Price
Market cap
EV
EBITDA
21,237
(28,477)
(30,112)
EV/EBITDA
Interest
200
227
23
Interest/NOPBT
1.13%